Results 11 to 20 of about 20,268 (224)

Obesity and HFpEF

Journal of Clinical Medicine, 2022
Heart failure with preserved ejection fraction (HFpEF) has represented a therapeutic challenge in recent decades [...]
Clemenza, Francesco, Citarrella, Roberto, Patti, Angelo, Rizzo, Manfredi   +3 more
openaire   +3 more sources

Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches

Рациональная фармакотерапия в кардиологии, 2021
Heart failure with preserved ejection fraction (HFpEF) is a syndrome associated with high morbidity and mortality rates. Little progress has been in the treatment of this condition since its introduction some 30 years ago.
A. A. Shchendrygina, K. A. Zhbanov, E. V. Privalova, A. O. Yusupova, Yu. A. Danilogorskaya, E. Yu. Salakheeva, I. Ya. Sokolova, S. A. Tsatsurova, A. A. Ageeva, Yu. N. Belenkov   +9 more
doaj   +1 more source

STEP-HFpEF: A Large Step for HFpEF. [PDF]

Journal of the American College of Cardiology
Contains fulltext : 307714.pdf (Publisher’s version ) (Open Access)
Kimmenade, R.R.J. van, Hassing, C.
openaire   +3 more sources

Heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus: pathophysiology and treatment options

Медицинский вестник Юга России, 2021
Type 2 diabetes mellitus is known to increase the risk of the development of heart failure with preserved ejection fraction and worsen its symptoms. To date, no specific treatment has been shown to reduce morbidity and mortality in patients with heart ...
A. A. Borisov, A. D. Gvozdeva, F. T. Ageev   +2 more
doaj   +1 more source

The Concept of "Heart Failure with Preserved Ejection Fraction": Time for a Critical Reappraisal

Reviews in Cardiovascular Medicine, 2023
Heart failure with preserved ejection fraction (HFpEF) is frequently observed in elderly physically deconditioned subjects, mainly women with hypertension, obesity, glucose intolerance/diabetes, atrial fibrillation, anaemia, coronary artery disease ...
Gabriele Fragasso
doaj   +1 more source

SGLT2 inhibitors: a new pillar of the heart failure regimen

Reviews in Cardiovascular Medicine, 2021
Initially intended as an adjunct treatment for type 2 diabetes mellitus (T2DM), SGLT2-inhibitors (SGLT2i) have transformed into an unexpected pillar of the heart failure (HF) regimen.
Travis DeSa, Timothy Gong   +1 more
doaj   +1 more source

β-Hydroxybutyrate Mitigated Heart Failure with Preserved Ejection Fraction by Increasing Treg Cells via Nox2/GSK-3β

Journal of Inflammation Research, 2021
Shengen Liao,1,* Yuan Tang,1,* Xin Yue,1 Rongrong Gao,1 Wenming Yao,1 Yanli Zhou,1 Haifeng Zhang2,3 1Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, People’s ...
Liao S, Tang Y, Yue X, Gao R, Yao W, Zhou Y, Zhang H   +6 more
doaj  

Comparing the Diagnostic Performance of HFA-PEFF and H2FPEF Scoring Systems in Heart Failure with Preserved Ejection Fraction Patients: Insights from the APOLLON Registry

Anatolian Journal of Cardiology, 2023
Background: Heart failure with preserved ejection fraction is a complex and heterogeneous clinical syndrome, poses significant diagnostic challenges.
Gurbet Özge Mert, Bülent Özlek, Eda Özlek, Hicaz Zencirkiran Ağuş, Mehmet Tekinalp, Serkan Kahraman, Cem Çil, Oğuzhan Çelik, Özcan Başaran, Volkan Doğan, Bedri Caner Kaya, İbrahim Rencüzoğulları, Altuğ Ösken, Lütfü Bekar, Mustafa Ozan Çakır, Yunus Çelik, Kadriye Memiç Sancar, Samet Sevinç, Murat Biteker, Kadir Uğur Mert   +19 more
doaj   +1 more source

Acute Decompensated Heart Failure in Patients With and Without COVID-19 — The Experience of a Romanian Center

Romanian Journal of Cardiology, 2022
Our goal was to characterize a cohort of heart failure patients with and without COVID-19 in terms of demographics, comorbid conditions, treatment regimens, lab test results and outcome.
Vintilă Ana-Maria, Horumbă Mihaela, Miron Paul, Balan Răzvan, Catrangiu Maria-Beatrice, Negoescu Iris-Andreea, Trifan Iuliana, Vintilă Vlad-Damian, Gurghean Adriana, Săvulescu-Fiedler Ilinca   +9 more
doaj   +1 more source

Potential Mechanisms of Epicardial Adipose Tissue Influencing HeartFailure with Preserved Ejection Fraction

Reviews in Cardiovascular Medicine
Heart failure (HF) is the predominant terminal stage and the leading cause ofmortality in cardiac disease. Heart failure with preserved ejection fraction(HFpEF) affects roughly 50% of HF patients globally.
Qiuxuan Li, Ur Rehman Muhib, Xiaoteng Ma, Zaiqiang Liu, Fei Gao, Zhijian Wang   +5 more
doaj   +1 more source